EDUCATIONAL OBJECTIVES

Following this symposium, participants will be able to:

• Discuss the latest progress on MCS for patients with advanced heart failure refractory to standard therapy
  
  
• Recognize the risk-benefit ratio of the timing of referrals with a focus on improving outcomes
  
  
• Identify the importance of collaborations between specialized heart failure centers and referring physicians in advancing the MCS field